The report provides a granular strategic analysis of over 100 clinical chemistries, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both centralized (hospitals, commercial laboratories), and POC/decentralized locations. The report explores future market trends; forecasts specimen, test and sales volume; estimates sales and market shares of key suppliers in major countries; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities for reagent and instrument suppliers. This new 75-country report is available by region, country, market segment, section, or individual test.

Clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.

Geographic Regions

Asia-Pacific, Europe, Latin America, Middle East, North America

Country Analyses

Argentina, Australia, Austria, Bahrain, Bangladesh, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Cyprus, Czech Republic, Denmark, Egypt, Estonia, Finland, France, Germany, Ghana, Greece, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Japan, Jordan, Kenya, Kuwait, Latvia, Lebanon, Lithuania, Malaysia, Malta, Mexico, Morocco, Myanmar, Netherlands, New Zealand, Nigeria, Norway, Oman, Pakistan, Peru, Philippines, Poland, Portugal, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, UK, United Arab Emirates, USA, Venezuela, Vietnam

Global Market Overview

- Estimates of facilities performing clinical chemistry and immunodiagnostic tests in major countries.

- Test volume and sales projections.

Market Segmentation Analysis

- Comprehensive review of the market dynamics, trends, structure, size, growth, and key suppliers.

- Test volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays.

Individual Tests Analyzed in the Report

Clinical Chemistry
Therapeutic Drug Monitoring (TDM)
Endocrine Function
Tumor Markers and Special Chemistry
Immunoproteins
Drugs of Abuse
Current and Emerging Products
Technology Review
Strategic Recommendations
Competitive Assessments
The companies analyzed in the report include:

   Abbott
   AdnaGen
   Agilent Technologies
   Bayer Healthcare
   Beckman Coulter/Danaher
   Biomedical Diagnostics
   Biomerieux
   Bio-Rad
   Diasorin
   Eiken Chemical
    Fujirebio
    Grifols
 

Category: Healthcare Market Research   

Contact Details:

Aarkstore Enterprise

+917710006788 | contact@aarkstore.com | aarkstore.com